64 related articles for article (PubMed ID: 529247)
1. Correlative studies of lymphocyte transformation and plasma protein levels in ankylosing spondylitis.
Kinsella TD
J Rheumatol; 1979; 6(6):621-8. PubMed ID: 529247
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of human lymphocyte transformation by aggregated human gamma globulin.
Kinsella TD
J Clin Invest; 1974 Apr; 53(4):1108-14. PubMed ID: 4131162
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis.
Blankenberg-Sprenkels SH; Fielder M; Feltkamp TE; Tiwana H; Wilson C; Ebringer A
J Rheumatol; 1998 Apr; 25(4):743-7. PubMed ID: 9558179
[TBL] [Abstract][Full Text] [Related]
4. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
J Rheumatol; 1999 Apr; 26(4):980-4. PubMed ID: 10229432
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated immunity in the rheumatoid diseases. I. Skin testing and mitogenic responses in sero-negative arthritides.
Froebel K; Sturrock RD; Dick WC; MacSween RN
Clin Exp Immunol; 1975 Dec; 22(3):446-52. PubMed ID: 1083785
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte response to IgG in patients with ankylosing spondylitis and their families.
Weisbart RH; Morris RI; Terasaki PI; Bluestone R; Goldberg LS
Clin Exp Immunol; 1976 Dec; 26(3):441-8. PubMed ID: 1087595
[TBL] [Abstract][Full Text] [Related]
8. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
Molenaar ET; Voskuyl AE; Familian A; van Mierlo GJ; Dijkmans BA; Hack CE
Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
[TBL] [Abstract][Full Text] [Related]
9. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte subpopulations in normals and patients with rheumatoid arthritis and ankylosing spondylitis.
Rosenthal M; Muller W
J Rheumatol; 1975 Dec; 2(4):355-8. PubMed ID: 1082029
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein: a marker for disease activity in ankylosing spondylitis and Reiter's syndrome.
Nashel DJ; Petrone DL; Ulmer CC; Sliwinski AJ
J Rheumatol; 1986 Apr; 13(2):364-7. PubMed ID: 3723498
[TBL] [Abstract][Full Text] [Related]
12. [Lymphocyte response to mitogens in serum-free and serum-containing medium in patients with rheumatoid arthritis (author's transl)].
Smolen JS; Menzel EJ; Scherak O
Wien Klin Wochenschr; 1978 Oct; 90(20):730-3. PubMed ID: 716428
[TBL] [Abstract][Full Text] [Related]
13. Nonspecific suppressor cells in rheumatoid arthritis. Con A and PHA induced suppressor cell activity.
Dunne JV; Sengar DP; Pearson D; McKendry RJ; Gardell D
J Clin Lab Immunol; 1982 Nov; 9(2):99-104. PubMed ID: 6218307
[TBL] [Abstract][Full Text] [Related]
14. Prolactin and growth hormone responses to hypoglycemia in patients with rheumatoid arthritis and ankylosing spondylitis.
Rovensky J; Imrich R; Malis F; Zlnay M; Macho L; Koska J; Vigas M
J Rheumatol; 2004 Dec; 31(12):2418-21. PubMed ID: 15570644
[TBL] [Abstract][Full Text] [Related]
15. Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.
Sanders KM; Hertzman A; Escobar MR; Littman BH
Ann Rheum Dis; 1987 Apr; 46(4):273-6. PubMed ID: 3592781
[TBL] [Abstract][Full Text] [Related]
16. Infliximab treatment reduces complement activation in patients with rheumatoid arthritis.
Familian A; Voskuyl AE; van Mierlo GJ; Heijst HA; Twisk JW; Dijkmans BA; Hack CE
Ann Rheum Dis; 2005 Jul; 64(7):1003-8. PubMed ID: 15958758
[TBL] [Abstract][Full Text] [Related]
17. [Blastic transformation of lymphocytes induced with PHA in ankylosing spondylitis].
Sadowska-Wróblewska M; Abgarowicz-Milkowska T; Filipowicz-Sosnowska A; Wierzchowska E
Reumatologia; 1976; 14(1):9-14. PubMed ID: 1257653
[No Abstract] [Full Text] [Related]
18. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation.
Divecha H; Sattar N; Rumley A; Cherry L; Lowe GD; Sturrock R
Clin Sci (Lond); 2005 Aug; 109(2):171-6. PubMed ID: 15801904
[TBL] [Abstract][Full Text] [Related]
20. [Plasma and intraerythrocytic zinc in rheumatoid arthritis and ankylosing spondylitis].
Mataran Pérez L; González Domínguez J; Rodríguez Pérez M; Rodrigo D; Abellán Pérez M; Salvatierra Ríos D
An Med Interna; 1989 Dec; 6(12):629-32. PubMed ID: 2491472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
